Skip to main content
. 2020 Nov 9;11(11):961. doi: 10.1038/s41419-020-03158-6

Fig. 2. Targeting CD44s inhibits the caspase-1/IL1B pathway.

Fig. 2

a, b Protein level of CD44s, caspase-1, and NLRP3 in five HCC cell lines were detected by western blot. The ratio of CD44s/GAPDH and caspase-1/CD44s was analyzed for the correlation. c Q-PCR analysis was performed to measure the mRNA expression of CASP1, NLRP3, and IL1B in control (siCon group) or CD44s deficient cells (siCD44 group). d, e Immunoblot analysis indicated that the caspase-1/IL1B pathway was inactivated in siCD44 cells. P10 refers to the active form of caspase-1. Cleaved IL1B refers to the mature form of IL1B. f Caspase-1 activity analysis showed CD44s knockdown inactivated caspase-1 capacity. Data are means ± SEM from 3 independent experiments, * means p < 0.05, ** means p < 0.01, *** means p < 0.001 by unpaired student t test.